These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7301005)

  • 1. Uremic 'toxins' and blood platelet carbohydrate metabolism.
    Tison P; Cernácek P; Silvánová E; Dzúrik R
    Nephron; 1981; 28(4):192-5. PubMed ID: 7301005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy production and utilization by human platelets in the presence of some guanidines and phenols (uremic toxins) that inhibit aggregation.
    Carroll HJ
    Thromb Diath Haemorrh; 1975 Sep; 34(1):63-71. PubMed ID: 1188836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.
    Horowitz HI; Stein IM; Cohen BD; White JG
    Am J Med; 1970 Sep; 49(3):336-45. PubMed ID: 5455565
    [No Abstract]   [Full Text] [Related]  

  • 4. Uremic toxins and platelet function.
    Horowitz HI
    Arch Intern Med; 1970 Nov; 126(5):823-6. PubMed ID: 5475705
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening uremic 'toxins' using bromsulfophthalein clearance by the isolated perfused rat liver.
    Liang MY; Toporek M; Schepartz B
    Nephron; 1978; 22(4-6):306-11. PubMed ID: 740090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    De Deyn PP; Macdonald RL
    Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of the effects of low-molecular uremic toxins on anaerobic metabolism of human erythrocytes].
    Kopczyński Z; Dryl-Rydzyńska T
    Pol Arch Med Wewn; 1991 Oct; 86(4):232-8. PubMed ID: 1813877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose metabolism in uremia.
    Quintanilla A; Shambaugh GE; Gibson TP; Craig R
    Am J Clin Nutr; 1980 Jul; 33(7):1446-50. PubMed ID: 6772007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory mechanism of platelet energy production and platelet functions by PGE1 and uremic toxins (author's transl)].
    Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):477-87. PubMed ID: 4799441
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations of cartilaginous aerobic glycolysis in the chronic uremic state.
    Russell JE; Avioli LV
    Kidney Int Suppl; 1975 Feb; (3):333-7. PubMed ID: 169426
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis.
    Karpatkin S
    J Clin Invest; 1967 Mar; 46(3):409-17. PubMed ID: 6023775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippurate participation in the inhibition of glucose utilization in renal failure.
    Spustová V; Dzúrik R; Geryková M
    Czech Med; 1987; 10(2):79-89. PubMed ID: 3115738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro.
    Weisensee D; Schnaars Y; Schoeppe W; Bereiter-Hahn J; Löw-Friedrich I
    Exp Nephrol; 1997; 5(3):194-200. PubMed ID: 9208278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of inhibitor of glucose utilization on the blood platelet function.
    Tison P; Kubisz P; Cernácek P; Dzúrik R
    Nephron; 1983; 33(4):253-6. PubMed ID: 6843756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the glycolytic pathway by methylglyoxal in human platelets.
    Leoncini G; Maresca M; Buzzi E
    Cell Biochem Funct; 1989 Jan; 7(1):65-70. PubMed ID: 2752537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine.
    Walkowiak B; Pawlowska Z; Michalak E; Cierniewski CS
    Thromb Haemost; 1994 Feb; 71(2):164-8. PubMed ID: 8191392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of deoxyglucose on platelet metabolism.
    Detwiler TC
    Biochim Biophys Acta; 1971 Aug; 244(2):303-10. PubMed ID: 5125612
    [No Abstract]   [Full Text] [Related]  

  • 19. Uremic toxins.
    Balestri PL; Biagini M; Rindi P; Giovannetti S
    Arch Intern Med; 1970 Nov; 126(5):843-5. PubMed ID: 5475707
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose metabolism in muscle of sedentary and exercised rats with azotemia.
    Davis TA; Klahr S; Karl IE
    Am J Physiol; 1987 Jan; 252(1 Pt 2):F138-45. PubMed ID: 3544866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.